Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer

REFERENCES

• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245–252.
   PubMed Web of Science ®Google Scholar
• Schlienger K, Chu CS, Woo EY, TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res 2003;9:1517–1527.
   PubMed Web of Science ®Google Scholar
• Santin AD, Hermonat PL, Ravaggi A, In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Am J Obstet Gynecol 2000;183:601–609.
   PubMed Web of Science ®Google Scholar
• Cannon MJ, O'Brien TJ. Cellular immunotherapy for ovarian cancer. Expert Opin Biol Ther 2009;9: 677–688.
   PubMed Web of Science ®Google Scholar
• Hsu FJ, Benike C, Fagnoni F, Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52–58.
   PubMed Web of Science ®Google Scholar
• Nestle FO, Banchereau J, Hart D. Dendritic cells: On the move from bench to bedside. Nat Med 2001;7:761–765.
   PubMed Web of Science ®Google Scholar
• Pardoll D. T cells and tumours. Nature 2001;411:1010–1012.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Chen HL, Girgis KR, Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996;2:1096–1103.
   PubMed Web of Science ®Google Scholar
• Zou W, Machelon V, Coulomb-L'Hermin A, Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001;7:1339–1346.
   PubMed Web of Science ®Google Scholar
• Curiel TJ, Wei S, Dong H, Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003;9:562–567.
   PubMed Web of Science ®Google Scholar
• Steinbrink K, Wolfl M, Jonuleit H, Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997;159:4772–4780.
   PubMed Web of Science ®Google Scholar
• Huarte E, Cubillos-RuizJR, Nesbeth YC, Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Res 2008;68:7684–7691.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Banerjee M, Cheng P, Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009;114:1141–1149.
   PubMed Web of Science ®Google Scholar
• Curiel TJ, Coukos G, Zou L, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942–949.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Zou L, Rodriguez P, B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006;203:871–881.
   PubMed Web of Science ®Google Scholar
• Wilke CM, Wu K, Zhao E, Prognostic significance of regulatory T cells in tumor. Int J Cancer 2010;127:748–758.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Wei S, Zhu G, Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007;67:8900–8905.
   PubMed Web of Science ®Google Scholar
• Wan T, Liu JH, Zheng LM, [Prognostic significance of tumor-associated macrophage infiltration in advanced epithelial ovarian carcinoma]. Ai Zheng 2009;28:323–327.
   Google Scholar
• Zou W, Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 2010;10:248–256.
   PubMed Web of Science ®Google Scholar
• Wilke CM, Kryczek I, Wei S, Th17 cells in cancer: Help or hindrance? Carcinogenesis 2011.
   Google Scholar
• Grouard G, Rissoan MC, Filgueira L, The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997;185:1101–1111.
   PubMed Web of Science ®Google Scholar
• Curiel TJ, Cheng P, Mottram P, Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res 2004;64:5535–5538.
   PubMed Web of Science ®Google Scholar
• Wei S, Kryczek I, Zou L, Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 2005;65:5020–5026.
   PubMed Web of Science ®Google Scholar
• Nelson BH. CD20+ B cells: The other tumor-infiltrating lymphocytes. J Immunol 2010;185: 4977–4982.
   PubMed Web of Science ®Google Scholar
• Milne K, Kobel.. M, Kalloger SE, Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One 2009;4:e6412.
   PubMed Web of Science ®Google Scholar
• Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6: 295–307.
   PubMed Web of Science ®Google Scholar
• Ziegler SF. FOXP3: Not just for regulatory T cells anymore. Eur J Immunol 2007;37:21–23.
   PubMed Web of Science ®Google Scholar
• Li Q, Teitz-Tennenbaum S, Donald EJ, In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy. J Immunol 2009;183:3195–3203.
   PubMed Web of Science ®Google Scholar
• Hagn M, Schwesinger E, Ebel V, Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol 2009;183:1838–1845.
   PubMed Web of Science ®Google Scholar
• Kemp TJ, Moore JM, Griffith TS. Human B cells express functional TRAIL/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation. J Immunol 2004;173:892–899.
   PubMed Web of Science ®Google Scholar
• Lundy SK. Killer B lymphocytes: The evidence and the potential. Inflamm Res 2009.
   Google Scholar
• Dong HP, Elstrand MB, Holth A, NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 2006;125:451–458.
   PubMed Web of Science ®Google Scholar
• Stashenko P, Nadler LM, Hardy R, Schlossman SF. Characterization of a human B lymphocyte-specific antigen. J Immunol 1980;125:1678–1685.
   PubMed Web of Science ®Google Scholar
• Stashenko P, Nadler LM, Hardy R, Schlossman SF. Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci U S A 1981;78:3848–3852.
   PubMed Web of Science ®Google Scholar
• Rosenthal P, Rimm IJ, Umiel T, Ontogeny of human hematopoietic cells: Analysis utilizing monoclonal antibodies. J Immunol 1983;131:232–237.
   Google Scholar
• Nadler LM, Anderson KC, Marti G, B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 1983;131:244–250.
   PubMed Web of Science ®Google Scholar
• Watt V, Ronchese F, Ritchie D. Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism. J Immunother 2007;30:323–332.
   Google Scholar
• Rodriguez-Pinto D. B cells as antigen presenting cells. Cell Immunol 2005;238:67–75.
   PubMed Web of Science ®Google Scholar
• Harris DP, Haynes L, Sayles PC, Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000;1:475–482.
   PubMed Web of Science ®Google Scholar
• Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008;20:332–338.
   PubMed Web of Science ®Google Scholar
• Deola S, Panelli MC, Maric D, Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions. J Immunol 2008;180:1362–1372.
   Google Scholar
• Whitmire JK, Asano MS, Kaech SM, Requirement of B cells for generating CD4+ T cell memory. J Immunol 2009;182:1868–1876.
   PubMed Web of Science ®Google Scholar
• Yanaba K, Bouaziz JD, Matsushita T, B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008;223:284–299.
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Riley EM. IL-10: The master regulator of immunity to infection. J Immunol 2008;180:5771–5777.
   PubMed Web of Science ®Google Scholar
• Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: A counterpoint. J Leukoc Biol 2005;78:1043–1051.
   PubMed Web of Science ®Google Scholar
• Murai M, Turovskaya O, Kim G, Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009;10:1178–1184.
   PubMed Web of Science ®Google Scholar